EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combination of ethyl acetate fraction from Calotropis gigantea stem bark and sorafenib induces apoptosis in HepG2 cells

Pattaraporn Chaisupasakul, Dumrongsak Pekthong, Apirath Wangteeraprasert, Worasak Kaewkong, Julintorn Somran, Naphat Kaewpaeng, Supawadee Parhira, Piyarat Srisawang iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0300051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Pattaraporn Chaisupasakul und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Medical Science, Naresuan University, Phitsanulok, Thailand. Hauptthemen laut MEDLINE: Calotropis, Liver Neoplasms, Acetates. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Research and Innovation Fund (NSRF) of Thailand, Faculty of Medical Science, Naresuan University, Agricultural Research Development Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cytotoxicity of the ethyl acetate fraction of the Calotropis gigantea (L.) Dryand. ( C . gigantea ) stem bark extract (CGEtOAc) has been demonstrated in many types of cancers. This study examined the improved cancer therapeutic activity of sorafenib when combined with CGEtOAc in HepG2 cells. The cell viability and cell migration assays were applied in HepG2 cells treated with varying concentrations of CGEtOAc, sorafenib, and their combination. Flow cytometry was used to determine apoptosis, which corresponded with a decline in mitochondrial membrane potential and activation of DNA fragmentation. Reactive oxygen species (ROS) levels were assessed in combination with the expression of the phosphatidylinositol-3-kinase (PI3K)/ protein kinase B (Akt)/ mammalian target of rapamycin (mTOR) pathway, which was suggested for association with ROS-induced apoptosis. Combining CGEtOAc at 400 μg/mL with sorafenib at 4 μM, which were their respective half-IC 50 concentrations, significantly inhibited HepG2 viability upon 24 h of exposure in comparison with the vehicle and each single treatment. Consequently, CGEtOAc when combined with sorafenib significantly diminished HepG2 migration and induced apoptosis through a mitochondrial-correlation mechanism. ROS production was speculated to be the primary mechanism of stimulating apoptosis in HepG2 cells after exposure to a combination of CGEtOAc and sorafenib, in association with PI3K/Akt/mTOR pathway suppression. Our results present valuable knowledge to support the development of anticancer regimens derived from the CGEtOAc with the chemotherapeutic agent sorafenib, both of which were administered at half-IC 50 , which may minimize the toxic implications of cancer treatments while improving the therapeutic effectiveness toward future medical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CalotropisLiver NeoplasmsAcetatesHumansSorafenibProto-Oncogene Proteins c-aktHep G2 CellsPhosphatidylinositol 3-KinasesReactive Oxygen SpeciesPlant BarkTOR Serine-Threonine KinasesPhosphatidylinositol 3-KinaseApoptosisCell Line, Tumor

Substanzen

SorafenibProto-Oncogene Proteins c-aktethyl acetatePhosphatidylinositol 3-KinasesReactive Oxygen SpeciesTOR Serine-Threonine KinasesPhosphatidylinositol 3-KinaseAcetates

Autor:innen und Institutionen

  • Department of Physiology, Faculty of Medical Science, Naresuan University, Phitsanulok, Thailand.
  • Center of Excellence for Innovation in Chemistry, Naresuan University, Phitsanulok, Thailand.
  • Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand.
  • Center of Excellence for Environmental Health and Toxicology, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand.
  • Department of Medicine, Faculty of Medicine, Naresuan University, Phitsanulok, Thailand.
  • Department of Biochemistry, Faculty of Medical Science, Naresuan University, Phitsanulok, Thailand.

ORCID-Profile: Piyarat Srisawang

Förderung

  • National Science Research and Innovation Fund (NSRF) of Thailand
  • Faculty of Medical Science, Naresuan University
  • Agricultural Research Development Agency
  • Center of Excellence for Innovation in Chemistry
  • Global and Frontier Research University Fund, Naresuan University

Zitieren

APA

Chaisupasakul, P., Pekthong, D., Wangteeraprasert, A., Kaewkong, W., Somran, J., Kaewpaeng, N., Parhira, S., & Srisawang, P. (2024). Combination of ethyl acetate fraction from Calotropis gigantea stem bark and sorafenib induces apoptosis in HepG2 cells. PLOS ONE. https://doi.org/10.1371/journal.pone.0300051

Vancouver

Chaisupasakul P, Pekthong D, Wangteeraprasert A, Kaewkong W, Somran J, Kaewpaeng N, et al. Combination of ethyl acetate fraction from Calotropis gigantea stem bark and sorafenib induces apoptosis in HepG2 cells. PLOS ONE. 2024. doi:10.1371/journal.pone.0300051

BibTeX
@article{Chaisupasakul2024,
  author = {Chaisupasakul, Pattaraporn and Pekthong, Dumrongsak and Wangteeraprasert, Apirath and Kaewkong, Worasak and Somran, Julintorn and Kaewpaeng, Naphat and Parhira, Supawadee and Srisawang, Piyarat},
  title = {Combination of ethyl acetate fraction from Calotropis gigantea stem bark and sorafenib induces apoptosis in HepG2 cells},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0300051}
}
Kostenlos starten →